
Investors’ data
Latest news
- July 12, 2010
THALLION ANNOUNCES 2010 SECOND QUARTER RESULTS
- June 24, 2010
THALLION ELIMINATES LONG-TERM LEASE OBLIGATION
- June 16, 2010
THALLION PHARMACEUTICALS RECEIVES ARBITRATION DECISION ON TLN-232 LICENSE AGREEMENT
Documentation
Investors Overview
Corporate Office
7150 Alexander-Fleming
Montreal, Quebec
H4S 2C8
Phone: 514-940-3600
Fax: 514-940-3622
